Trans-lymphatic Contrast-Enhanced Ultrasound in Combination with Blue Dye Injection is Feasible for Detection and Biopsy of Sentinel Lymph Nodes in Breast Cancer

Chen, Xiangmei; Zhong, Jieyu; Hu, Ziqiang; Wei, Wei; Wang, Yin; Cui, Ligang; Liu, Ji‐Bin; Sun, Desheng

doi:10.37015/audt.2018.180805

Advanced Ultrasound in Diagnosis and Therapy

2018

DOI: 10.37015/audt.2018.180805

|View full text |Cite

Trans-lymphatic Contrast-Enhanced Ultrasound in Combination with Blue Dye Injection is Feasible for Detection and Biopsy of Sentinel Lymph Nodes in Breast Cancer

Xiangmei Chen¹,

Jieyu Zhong²,

Ziqiang Hu³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

2022

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Advanced diagnostic imaging of sentinel lymph node in early stage breast cancer

Sun

2022

J of Clinical Ultrasound

View full text Add to dashboard Cite

Sentinel lymph node biopsy has been regarded as the standard procedure for early staging breast cancer. One of the key steps is to locate the sentinel lymph node (SLN). The recommended method is the joint use of blue dye and radioisotope. However, due to radionuclide radiation and high cost, it is urgent to develop more convenient and sensitive imaging methods to accurately locate SLN. This article discusses the advancement of accurately locating SLN by isotope tracer imaging, magnetic tracer method, computed tomographic lymphography, and trans‐lymphatic contrast‐enhanced ultrasound, as well as proposing new propose for clinical diagnosis.

show abstract

Advanced diagnostic imaging of sentinel lymph node in early stage breast cancer

Sun

2022

J of Clinical Ultrasound

View full text Add to dashboard Cite

show abstract

Feasibility and efficiency of contrast enhanced ultrasound real time guided fine needle aspiration for sentinel lymph node of breast cancer

Shi

Zhang

Liu

et al. 2022

View full text Add to dashboard Cite

AIM: To assess the feasibility and efficiency of contrast-enhanced ultrasound (CEUS) real-time guided fine needle aspiration (FNA) for sentinel lymph node (SLN) of breast cancer. MATERIALS AND METHODS: This retrospective study reviewed 21 breast cancer patients who scheduled for surgical resection performed CEUS real-time guided SLN-FNA and intraoperative SLN biopsy (SLNB). The success rate of CEUS real-time guided SLN-FNA was analyzed. The FNA diagnostic efficiency of SLN metastasis was analyzed compared to SLNB. RESULTS: Twenty-six SLNs were detected by intradermal CEUS whereas 130 SLNs were detected by SLNB. The median SLNs detected by intradermal CEUS (n = 1) and by SLNB (n = 5) was significantly difference (p < 0.001). All 26 CE-SLNs of 21 patients were successfully performed intradermal CEUS dual image real-time guided SLN-FNA including 5 SLNs of 4 patients which were difficult to distinguish in conventional ultrasound. Compared to SLNB, FNA found 2 of 5 cases of SLN metastasis, the diagnosis sensitivity, specificity, positive predictive value, negative predictive value, false negative rate, false positive rate and Yoden index were 40%, 100%, 100%, 84.2%, 60%, 0%and 40%, respectively. CONCLUSION: SLN-FNA real-time guided by dual CEUS image mode was technically feasible. Patients with a positive SLN-FNA should be advised to ALND without intraoperative SLNB according to Chinese surgeon and patients’ conservatism attitude. But a negative SLN-FNA did not obviate the need of conventional SLNB because of the high false negative rate.

show abstract

Current Status and Advances in Imaging Evaluation of Neoadjuvant Chemotherapy of Breast Cancer

Hu¹,

Li²,

Zhou³

2021

Advanced Ultrasound in Diagnosis and Therapy

View full text Add to dashboard Cite

It is particularly important to evaluate the efficacy of neoadjuvant chemotherapy (NAC) for breast cancer. This article reviews the current status and progress of imaging evaluations regarding the efficacy of NAC in women with breast cancer, including mammography, ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET-CT) and radiomics. Each imaging method has value for evaluating the efficacy of NAC for breast cancer, but certain defects and limitations. Therefore, the optimal selection will employ a combination of multiple imaging methods that will not only benefit patients but also avoid the unnecessary waste of medical resources.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Trans-lymphatic Contrast-Enhanced Ultrasound in Combination with Blue Dye Injection is Feasible for Detection and Biopsy of Sentinel Lymph Nodes in Breast Cancer

Cited by 3 publications

References 0 publications

Advanced diagnostic imaging of sentinel lymph node in early stage breast cancer

Advanced diagnostic imaging of sentinel lymph node in early stage breast cancer

Feasibility and efficiency of contrast enhanced ultrasound real time guided fine needle aspiration for sentinel lymph node of breast cancer

Current Status and Advances in Imaging Evaluation of Neoadjuvant Chemotherapy of Breast Cancer

Contact Info

Product

Resources

About